DOCSLIB.ORG

R&D Conference 2014

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
R&D Conference 2014 Pharmaceutical Services Division Ministry of Health Malaysia th NATIONAL PHARMACY 8R&D CONFERENCE 2014 Quality R&D: Transforming Universal Excellence 10 - 12 JUNE 2014 GRAND BLUE WAVE HOTEL SHAH ALAM Organised By: In collaboration with: Pharmaceutical Services Division Malaysian Pharmaceutical Ministry of Health Malaysia Society CONTENT Foreword from the Honourable Minister of Health Malaysia ............................................................. 2 Welcome Message from the Director General of Health Malaysia ................................................ 3 Welcome Message from the Senior Director of the Pharmaceutical Services, MOH Malaysia.......................................................................................................................................................... 4 Message from Chairman of Organising Committee............................................................................. 5 Organising Committee & Sub-Committees ............................................................................................. 6 Chronology of National Pharmacy R&D Conferences 2002 –2014 ........................................... 8 Theme & Objectives ............................................................................................................................................ 9 Conference Programme Outline ..................................................................................................................10 Pre- Conference Workshop Programme ..................................................................................................11 Conference Programme ...................................................................................................................................12 Plenary Speakers & Synopsis of Plenary Presentations .....................................................................15 Judges ......................................................................................................................................................................19 List of Oral & Poster Presentations ............................................................................................................. 20 Compendium of Abstracts • Oral Presentations ..................................................................................................................................... 29 • Poster Presentations ................................................................................................................................. 71 Winners of 7th National Pharmacy R&D Conference 2012 ............................................................ 90 Acknowledgements .......................................................................................................................................... 92 Location Plan ........................................................................................................................................................ 93 8TH NATIONAL PHARMACY R&D CONFERENCE 2014 2 QUALITY R&D: TRANSFORMING UNIVERSAL EXCELLENCE FOREWORD FROM THE HONOURABLE MINISTER OF HEALTH MALAYSIA Salam sejahtera and Salam 1Malaysia, On behalf of the Ministry of Health Malaysia, I would like to extend our heartfelt congratulations to the Pharmaceutical Services Division, Ministry of Health for their efforts and dedication in organising the 8th National Pharmacy Research and Development Conference.I am glad to receive the invitation to officiate this biennial conference which brings together researchers to present the outcomes of their diverse research activities. The theme of this conference, Quality R & D: Transforming Universal Excellence is very much in line with the current situation in our country which is moving towards globalization. Hence, it is a necessity for products and services of the Ministry to fulfill quality specifications and is geared towards the national goal. I am glad to note that pharmacists have contributed significantly to research and development and this fact can be ascertained from this conference that has been organised for the eighth time. I suggest that outcomes of all successful presentations are consolidated to derive new policy decisions applicable for improving service provision by pharmacists and other healthcare providers in our facilities. It is undeniable that the Ministry is ever evolving to strive for the betterment in the service provision to its customers. I hope this conference will recognise new research talents who can be trained and inspired to lead future budding researchers. This is important because it is parallel with the objectives of the Entry-Point Project (EPP) 2 under Healthcare in the Economic Transformation Programme and the Country Health Plan: 10th Malaysian Plan 2011-2015, which is creating an ecosystem that supports the growth of clinical research and other health sector transformation. Pharmacists and other health providers must come together to contribute in research to achieve the ministry and country’s goals. Once again, I congratulate the Pharmaceutical Services Division for taking the initiative to organise this conference. Thank you. YB DATUK SERI DR. S. SUBRAMANIAM Minister of Health Malaysia 8TH NATIONAL PHARMACY R&D CONFERENCE 2014 QUALITY R&D: TRANSFORMING UNIVERSAL EXCELLENCE 3 WELCOME MESSAGE FROM THE DIRECTOR GENERAL OF HEALTH MALAYSIA Assalamualaikum warahmatullahi wabarakatuh Salam 1Malaysia It gives me great pleasure to welcome all participants to the 8th National Pharmacy Research and Development Conference 2014. I am delighted that this biennial conference, jointly organised by the Pharmaceutical Services Division (PSD), Ministry of Health (MOH) and the Malaysian Pharmaceutical Society (MPS), reflects a successful public private partnership to achieve common goals towards betterment of health. I am happy to note that the objectives of this conference are in accordance with the 67th World Health Assembly document, dated 25 Jan 2014, which stated that “support for research and development is important for the sustainable supply of future essential medicines, to address public health needs”. I sincerely urge researchers to focus on the National Health Research Priority Areas, as outlined by the MOH in the 10th Malaysian Plan. Based on research findings, the Ministry will be in a better position to formulate policies in healthcare for the general public. It is encouraging to see the participation and involvement of multidisciplinary teams from MOH, members of the academia, both from the public and the private sectors, as well as local and international circles. I expect the participants will acquire a wealth of knowledge which can be implemented in their workplace. This ripple effect will ultimately support the Ministry’s efforts in preparing for a well-informed consumer on medicines and healthcare. I would like to congratulate the PSD, MPS and the various committee and subcommittee, and all oral and poster presenters for making this conference a great milestone for the MOH this year. Wassallam and thank you. YBHG. DATUK DR. NOOR HISHAM BIN ABDULLAH Director General of Health Malaysia 8TH NATIONAL PHARMACY R&D CONFERENCE 2014 4 QUALITY R&D: TRANSFORMING UNIVERSAL EXCELLENCE WELCOME MESSAGE FROM THE SENIOR DIRECTOR OF THE PHARMACEUTICAL SERVICES Assalamualaikum warahmatullahi wabarakatuh and Salam 1 Malaysia First and foremost, I would like to express my highest and utmost gratitude to Allah s.w.t for granting us all, the chance and opportunity to hold the 8th National Pharmacy Research and Development (R&D) Conference, 2014. This event would not be a success without the co-operation, co-ordination and hard work of everyone in the Pharmaceutical Services Division (PSD), MOH and the Malaysian Pharmaceutical Society. A special mention to the Selangor State Health Department for hosting this year’s event. The theme for this year, “Quality R&D: Transforming Universal Excellence” is the continuation of the previous conference. This is in line with the mission of fulfilling the country’s needs, in aiming towards becoming a developed country by the year 2020. Thus, all new R&D projects conducted by our pharmacists must be at par or better than the universal standards. Therefore, we must ensure that our findings are of high quality and standards, hence accountable and able to compete internationally. As the Head of Profession, I give my full support to address these challenges. It is evident that the focus of this year’s conference is more on topics pertaining to clinical and pharmacy practice. This will certainly assist in promoting rationale prescribing and dispensing practices, as well as tackling pharmaceutical care issues in hospitals and clinics nationwide. With such emphasis and extensive R&D, I hope we will achieve the expected outcomes, satisfy our customers and assist in reducing costs. It is encouraging that this conference has received good participation as affirmed by the large number of research applications received by the organising committee. It clearly indicates the interest of our pharmacists and other healthcare personnel in pursuing R&D activities. I hope research continues to be a culture among the pharmacists and other healthcare providers, so that the principle of continuous improvement, or kaizen, is applied at all levels of services.Therefore, I would urge everyone to give more attention towards the outcomes of research to improve the healthcare of the public at large. Finally, my sincere thanks and gratitude to the Director
Load more

Recommended publications
  • (COVID-19) SITUATION in MALAYSIA 6 October 2020
    PRESS STATEMENT MINISTRY OF HEALTH MALAYSIA UPDATES ON THE CORONAVIRUS DISEASE 2019 (COVID-19) SITUATION IN MALAYSIA 6 October 2020 Current Status of Confirmed COVID-19 Cases Who Have Recovered The Ministry of Health (MOH) would like to inform that 87 cases have fully recovered and discharged today. Cumulatively, 10,427 confirmed COVID-19 cases have been discharged (77.2% of total cumulative cases). Current Situation of COVID-19 in Malaysia 6 October 2020, 12 pm, MOH would like to inform that 394 cases were detected in the Tembok Cluster, a prison in Kedah (i.e. 57.0% of the total cases reported today), 294 cases from other localities and three (3) imported cases. In total, 691 additional confirmed COVID-19 cases were reported to the National Crisis Preparedness and Response Centre (CPRC) MOH today. Cumulatively there are now 13,504 confirmed COVID-19 cases in Malaysia. Therefore, there are currently 2,936 active and infective COVID-19 cases. They have all been isolated and given treatment. Of the 691 cases reported today, three (3) are imported cases who were infected overseas, involving one (1) Malaysian and two (2) non- Malaysian who were travellers from: • India – 1 case reported in Kuala Lumpur, a Malaysian. • Egypt – 1 case reported in Sarawak, a non-Malaysian. • Philippines – 1 case reported in Selangor, a non-Malaysian. Of the 688 local transmission cases, 661 cases are Malaysians and 27 cases non-Malaysians. Of the 688 cases, 394 cases are those detected in the Tembok Cluster, a prison in Kedah (57.0% of total cases reported today).
    [Show full text]
  • 1. MOA AAA 2016 Abstract
    Abstract Combined Meeting of the th Malaysian Orthopaedic 46Association Annual General Meeting / Annual Scientific Meeting th ASEAN Arthroplasty 10 Association Meeting 2016 Fundamentals In Orthopaedics – Back To Basics Pre-Conference Day Conference Days 25th May 2016 26th to 28th May 2016 Persada Johor International Convention Centre, Johor Bahru, Malaysia. www.moa-home.com Abstract CD (Please click on the links below to view the respective categories of abstracts.) Oral Presentations Abstracts Poster Presentations Abstracts (Click Here...) Combined Meeting of the 46th Malaysian Orthopaedic Association Annual General Meeting / Annual Scientific Meeting & 10th ASEAN Arthroplasty Association Meeting 2016 26th May 2016 (Thursday) - Lecture Hall MOA 1, Level 3 TIME TOPIC SPEAKER 0700 -1730 REGISTRATION COUNTER OPENS SUBIR SENGUPTA MEMORIAL LECTURE Chairperson Prof Dr Saw Aik 0830 - 0900 Prevention And Early Detection Of DDH - The Japanese SM 01 Prof Dr Makoto Kamegaya Experience OPENING CEREMONY 0900 - 1030 Orthopaedics At The Frontlines In A Changing Globalised World. SK 01 Roles And Responsibilities. Dato' Dr Ahmad Faizal Mohd Perdaus A View From A Humanitarian And Colleauge. 1030 - 1100 TEA BREAK & EXHIBIT VISIT SPORTS Dr Shamsul Iskandar Hussein Chairperson Dr Raymond Yeak Dieu Kiat Revision Anterior Cruciate Ligament Reconstruction: Analysis 1100 - 1112 SX 01 Of Causes Of Failures, Preoperative Clinical Evaluation And Dr Deepak V. Patel Planning, Surgical Technique, And Clinical Outcomes SLAP (Superior Labrum Anterior Posterior)
    [Show full text]
  • Nursing Division Ministry of Health Malaysia
    NURSING DIVISION MINISTRY OF HEALTH MALAYSIA First Edition Mei 2017 SAFE OPERATING PROSEDURE FOR ADMINISTRATION OF INTRAVENOUS ( BOLUS ) EDICATION SAFE OPERATING PROSEDURE FOR ADMINISTRATION OF INTRAVENOUS ( BOLUS ) EDICATION ACKNOWLEDGEMENT Nursing Division Ministry of Health Malaysia gratefully acknowledges the expert contributions made by the following members, without whom the development of this consensus document would not be possible. ADVISOR Puan Hajah Rosena binti Abdul Ghani Director of Nursing Division, MOH EDITIORS Dr. Nor’Aishah Binti Abu Bakar Head of Patient Safety Unit Senior Public Health Physician & Senior Principle Assistant Director Medical Care Quality Section Medical Development Division, Ministry of Health Malaysia Puan Monica Chee Soon Nyuk Senior Assistant Director of Nursing, Nursing Division, MOH Puan Ng Siew Luan Nursing Matron, Nursing Division, MOH TECHNICAL WORKING GROUP Puan Darmawan binti Ramli Nursing Tutor, Unit Curriculum, Nursing Division, MOH Puan Suzana binti Jaafar Assistant Director, Nursing Division. MOH Puan Norlaila binti Mohd Husin Assistant Director, Nursing Division. MOH Puan Zanita binti Ahmad Clinical Nursing Matron, Family Health Development Division, MOH Puan Razmiyah binti Awang Nursing Matron, Nursing Division, MOH Puan See Booi Cheng Nursing Matron, Family Health Development Division, MOH Puan Noor Wati binti Esa Nursing Matron, Kuala Lumpur General Hospital Puan Mariati binti Alias Nursing Matron, Putrajaya Hospital Puan Noorsiah binti Harun Nursing Matron, Kajang Hospital Puan Zalimah
    [Show full text]
  • Changing of the Guard
    MONASH PHARMACY AND PHARMACEUTICAL SCIENCES Changing of the Guard Meet our new Dean Going Global: The faculty’s ISSUE 34 • SUMMERISSUE 34 2019/20 increasingly international face John and Nariel Ware endow new scholarship Alumni news Fast Facts 2017 CLARIVATE ANALYTICS HIGHLY CITED RESEARCHERS (2004–2014) No.1 worldwide in Pharmacology and Toxicology QS WORLD UNIVERSITY RANKINGS BY SUBJECT, PHARMACY AND PHARMACOLOGY No.1 in Australia and Asia-Pacific 2018 No.1 worldwide for academic reputation 2018 No.2 worldwide 2018 Top 10 worldwide (average 2011–2018) Excellence in Research for Australia 2015 Top rating of 5 in all sectors (well above world standard) PharmAlliance with University of North Carolina at Chapel Hill, US and University College London, UK National Alliance for Pharmacy Education with University of Queensland, University of Sydney University of South Australia MONASH PHARMACY AND PHARMACEUTICAL SCIENCES Fast Facts Contents 02 News in brief Alchemy is produced 2017 CLARIVATE ANALYTICS by the Development Office, HIGHLY CITED RESEARCHERS (2004–2014) 04 Dean Charman steps down Faculty of Pharmacy and Pharmaceutical Sciences, No.1 worldwide in Pharmacology and Toxicology 06 Research with impact Monash University. Managing Editor: John Palmer 10 Special feature: Going global Writers: Rahul Ratwatte, Cyndi Ferguson, QS WORLD UNIVERSITY RANKINGS BY SUBJECT, Divya Krishnan 11 Monash University Malaysia’s School of Pharmacy Design: BPO Intelligence PHARMACY AND PHARMACOLOGY celebrates 10 years Photography: Paul Philipson and Greg Ford
    [Show full text]
  • Risk Factors Associated with Necrotising Enterocolitis in Very Low Birth Weight Infants in Malaysian Neonatal Intensive Care Units
    O riginal A rticle Singapore Med J 2012; 53(12) : 826 Risk factors associated with necrotising enterocolitis in very low birth weight infants in Malaysian neonatal intensive care units Nem-Yun Boo1, MRCP, FRCPCH, Irene Guat Sim Cheah2, MRCP, FRCPCH; Malaysian National Neonatal Registry Introduction This study aimed to identify the risk factors associated with necrotising enterocolitis (NEC) in very low birth weight (VLBW; weight < 1,501 g) infants in Malaysian neonatal intensive care units (NICUs). Methods This was a retrospective study based on data collected in a standardised format for all VLBW infants born in 2007 (n = 3,601) and admitted to 31 NICUs in Malaysian public hospitals. A diagnosis of NEC was made based on clinical, radiological and/or histopathological evidence of stage II or III, according to Bell’s criteria. Logistic regression analysis was performed to determine the significant risk factors associated with NEC. ResuLts 222 (6.2%) infants developed NEC (stage II, n = 197; stage III, n = 25). 69 (31.3%) infants died (stage II, n = 58; stage III, n = 11). The significant risk factors associated with NEC were: maternal age (adjusted odds ratio [OR] 1.024, 95% confidence interval [CI] 1.003–1.046; p = 0.027), intrapartum antibiotics (OR 0.639, 95% CI 0.421–0.971; p = 0.036), birth weight (OR 0.999, 95% CI 0.998–0.999; p < 0.001), surfactant therapy (OR 1.590, 95% CI 1.170– 2.161; p = 0.003), congenital pneumonia (OR 2.00, 95% CI 1.405–2.848; p < 0.001) and indomethacin therapy for the closure of patent ductus arteriosus (PDA) (OR 1.821, 95% CI 1.349–2.431; p = 0.001).
    [Show full text]
  • Crc Sabah Newsletter
    Issue 3 : September– December 2013 CRC SABAH NEWSLETTER Inside This Issue WELCOME TO ISSUE 3 OF CRC NEWSLETTER Welcome to Issue 3 of CRC Sabah Newletter Warmest Greeting from CRC Sabah! Welcome 2014, and Happy Investigator Initiated Research (IIR) New Year! As we begin this New Year, we hope that 2014 will and industry Sponsored Research bring bigger and better things for the Clinical Research Centre (ISR) updates (CRC). Activities and Photo Gallery In This issue, we want to announce the upcoming workshop organized by CRC Sabah for the year 2014. Contact Us 1. Good Clinical Practice (GCP) Workshop collaboration Upcoming Events with Clinical Research Malaysia (CRM) 19th – 21st Feb 2014, Sabah Women and Children Hospital. 2. Sabah Good Clinical Practice (GCP) Workshop 26th – 28th Mar 2014, Hospital Queen Elizabeth II. CRC’s OBJECTIVE 3. Basic to Intermediate Medical Biostatistics Using SPSS Workshop 2014 1. To promote a culture of 14 – 17 April 2014, School Of Medical, University Malaysia research among healthcare Sabah (UMS). workers in Sabah. 4. Advanced Medical Biostatistics Using SPSS Workshop 2014 2 – 6 Jun 2014, School Of Medical, University Malaysia Sabah (UMS). 2. To disseminate skills in Grab this opportunity and never stop Learning! See you there! Methodology, Statistical tools, and techniques in designing and conducting clinical trials. CRC’s Vision 3. To provide healthcare workers the principle of methodology and To be a leading clinical research institution in Asia biostatistics in clinical research CRC’s Mission To improve patients health outcomes through ethical and quality clinical research. ISSUE 3: September – December 2013 CRC Sabah Newsletter MESSAGE AND RESOLUTION CRC SABAH HEAD 2014 First and foremost, I would like to congratulate the editorial team for their success in publishing the third edition of CRC Sabah Newsletter.
    [Show full text]
  • Curriculum Vitae BIODATA Name Zaiton Kamarruddin P.C.M IC 630624-08-5388 Age 58
    Curriculum Vitae BIODATA Name Zaiton Kamarruddin P.C.M IC 630624-08-5388 Age 58 Nationalilty Malaysian State Health Deputy Director (Pharmacy) Current State Health Department Position Perak Darul Ridzuan c/o Hospital Bahagia Ulu Kinta 31250 Tanjung Rambutan Address Perak Darul Ridzuan. Email [email protected] Contact Off : 605-5337318 ACADEMIC ACHIEVEMENTS PhD Program ( Health Sciences)( 2001-2005) 2001-2005 CURTIN University of Technology, Perth, WA M.Pharm (Clinical Pharmacy) – University of Science Malaysia (USM). 1994 Penang (1994) 1987 B. Pharm (Hons)- University of Science Malaysia (USM). Penang (1987) WORK ACHIEVEMENTS / AWARD 2013 Excellent Service Award, Public Service MOH 2012, by JKN Selangor 2012 Excellent Service Certificate, December 2012, Hospital Kajang. 2001 Excellent Service Award, Public Service 2012, by JKN Perak Awarded by the Competency Unit, Ministry of Health, Malaysia for Excellent Efficiency. (PTK 4) 2020 Anugerah Darjah Kebesaran, Bintang Dan Pingat Negeri Perak Tahun 2020 - `PADUKA CURA SI MANJA KINI ` (P.C.M) Page 1 of 12 WORK EXPERIENCES Head of Unit (LEAN), 2019 -2020 Centre for Organizational Excellence Development Institute for Health Management, Ministry of Health Malaysia (MOH) Core Business: Research, Training and Consultancy related to LEAN Healthcare / Management 2014-2018 Head of Division, Healthcare Quality Research Division,Institute for Health Systems Research (IHSR),Ministry of Health Malaysia. Project Leader in Lean Healthcare Initiatives of MOH under Government Transformation Program (GTP)
    [Show full text]
  • IOI Corporation Berhad, Sakilan Group Sandakan, Sabah, Malaysia
    PUBLIC SUMMARY REPORT INITIAL RSPO CERTIFICATION ASSESSMENT IOI Corporation Berhad, Sakilan Group Sandakan, Sabah, Malaysia Report Author Allan Thomas – 21 st April 2009 [email protected] Tel: +61 412 492 353 BSi Management Systems Singapore Pte Ltd ( Co. Reg. 1995 02096-N) Malaysia Office (Co.Reg. 9942MX) 460 Alexandra Road Suite 19.05 Level 19, Wisma Goldhill #08-01/02 PSA Building 65, Jalan Raja Chulan SINGAPORE 119963 50200 Kuala Lumpur Tel +65 6270 0777 MALAYSIA Fax +65 6270 2777 Tel +60 32032 2252 (Hunting Line) www.bsi-asia.com Fax +60 32032 2253 Soon Leong Chia: [email protected] Teo Chin Siong: [email protected] TABLE of CONTENTS Page N o SUMMARY…… .....................................................................................................................................1 Abbreviations USED................................................................................................................................1 1.0 Scope of Certification Assessment.................................................................................................1 1.1 National Interpretation Used..........................................................................................................1 1.2 Certification Scope.........................................................................................................................1 1.3 Location and Maps.........................................................................................................................1 1.4 Description of Supply
    [Show full text]
  • 3Rd Report of the National Cataract Surgery Registry 2004
    National Cataract Surgery Registry Ministry of Health Malaysia THE THIRD REPORT OF THE NATIONAL CATARACT SURGERY REGISTRY 2004 Edited by Goh Pik Pin Shamala Retnasabapathy Rajalakshmi Gopal Ronald Arun Das A publication of the National Cataract Surgery Registry And Clinical Research Centre, Ministry of Health October 2004 © National Cataract Surgery Registry, Malaysia. Published by the National Cataract Surgery Registry (NCSR) C/O Clinical Research Centre, Level 3, Dermatology Block, Kuala Lumpur Hospital, Jalan Pahang, 50586 Kuala Lumpur. General Line: 603-2698 0310 Fax: 603-2691 1682 Email [email protected] Website: http://www.crc.gov.my/ncsr Disclaimer The data reported here have been supplied by NCSR. The interpretation and reporting of these data are the responsibility of the Editor and in no way should be seen as an official policy or interpretation of the NCSR. Suggested citation The suggested citation for this report is as follows: Goh Pik Pin, Shamala Retnasabapathy, Rajalakshmi Gopal, Ronald Arun Das.(Eds) THE SECOND REPORT OF THE NATIONAL CATARACT SURGERY 2003 Kuala Lumpur, Malaysia 2004 Electronic version Electronic version of this report can be downloaded at http://www.crc.gov.my/ncsr ISSN 1675-8447 Forward i ACKNOWLEDGMENTS i National Cataract Surgery Registry Advisory Committee i PARTICIPATING CENTRES 1. Angkatan Tentera Kem Terendak Hospital Head, Ophthalmology Department : Lt. Kol. (Dr) Nor Aishah Malik Dr In Charge : - Coordinator : Sarjan Jawariah Ali Participating From : January-November 2002 January-December 2003 2 Alor Setar Hospital Head, Ophthalmology Department : Dr. Ahmad Mat Saad Dr In Charge : Dr. Zaharidah Abd Kadir Coordinator : T/AN Siti Aishah Salim Participating From : January-December 2002 January-December 2003 3 Duchess Of Kent Hospital, Sandakan Head, Ophthalmology Department : Dr.
    [Show full text]
  • List of Medical Practitioners Registered, 1983
    [2315) OF INESTURN AUSTRALIA (Published by Authority at 3 .30 p .m .) No . 48] PERTH: TUESDAY, 5 JULY [1983 MEDICAL ACT 1894-1979 the Medical Board of Western Australia LIST OF M EDICAL PRACTITIONERS REGISTERED, 1983 26843/6/83 THE MEDICAL BOARD OF WESTERN AUSTRALIA 44 Ventnor Avenue, West Perth, 6005 . THE following list of Medical Practitioners is published in accordance with section 14 of the Medical Act 1894-1979 . 1st May, 1983 . Medical Practitioners who have complied with section 16A of the Act are indicated thus : K .I . BRADBURY, Registrar . Original No . Name Address Qualifications Date of Registration *5912 Abbott, John Stephen 206 Stirling Street, MB BS West Aust 1978 10/1/78 Perth WA 6000 5655 Abraham, Rex Leslie 11 Moon Street, MB BS Qld 1977 14/2/78 Balina NSW 2478 *6278 Abrugiato, Robert 6 Hillside Road, MB BS West Aust 1980 8/1/80 East Fremantle WA 6158 *2779 Achimovich, Lois Mary 160 High Street, MB BS West Aust 1966 ; MRANZCP 1973 14/12/65 Fremantle WA 6160 *2500 Adams, Arthur Richard 301 Geographe Bay Road, MB ChB Aberd 1949 ; MRCP Edin 1960 ; 10/3/64 Quindalup WA 6281 FRCP Edin 1972 *6446 Adams, David Watson Scott C/- Dr G Moffat, 98 Wellington Street, MB ChB Dundee 1975 12/1/82 Northam WA 6401 *2518 Adams, Pacricia Mary MacBride 301 Geographe Bay Road, MB ChB Edin 1948 14/7/64 Quindalup WA 6281 N 3652 Adams, Tine 1 Goldsmith Street, MB BS West Aust 1972 11/1/72 Parap NT 5790 *2457 Adamson, John Edmund Bernard 17 MacLeod Road, MB BS West Aust 1963 ; MRCP Edin 1968 11/1/63 Applecross WA 6153 *5770 Adamson, Roslyn Mary
    [Show full text]
  • The Functional Outcome of Patients Following Spinal Injury in Asia Metropolitans: Does the Prehospital Spine Immobilization Matter?
    The Functional Outcome of Patients Following Spinal Injury in Asia Metropolitans: Does the Prehospital Spine Immobilization Matter? Hsuan An Chen Far Eastern Memorial Hospital Shuo Ting Hsu Far Eastern Memorial Hospital Sang Do Shin Seoul National University College of Medicine and Hospital Sabariah Faizah Jamaluddin Universiti Teknologi MARA Do Ngoc Son Bach Mai Hospital Ki Jeong Hong Seoul National University College of Medicine and Hospital Hideharu Tanaka Graduate School of Kokushikan University Jen Tang Sun Far Eastern Memorial Hospital Wen-Chu Chiang ( [email protected] ) National Taiwan University Hospital Research Article Keywords: Patients, Spinal Injury, Prehospital, Immobilization Posted Date: July 27th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-724919/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/15 Abstract Prehospital spinal immobilization is a widely used procedure in the emergency medical service (EMS) system worldwide, while the incidence of patients with spinal injury (SI) is relatively low, and unnecessary prehospital spinal immobilization is associated with patient complications. This study aimed to determine the association between prehospital spine immobilization and favorable functional outcomes at hospital discharge among trauma patients with SI. We conducted a retrospective cohort study using the Pan-Asia Trauma Outcomes Study (PATOS) registry data from January 1, 2016, to November 30, 2018. A total of 759 patients with SI were enrolled from 43,752 trauma patients in the PATOS registry during the study period. The subjects had a median age of 58 years ( Q1−Q3,41−72), and 438 (57.7%) patients had prehospital spine immobilization.
    [Show full text]
  • Surgical Site Infection After Gastrointestinal Surgery in Children: an International, Multicentre, Prospective Cohort Study
    Original research BMJ Glob Health: first published as 10.1136/bmjgh-2020-003429 on 3 December 2020. Downloaded from Surgical site infection after gastrointestinal surgery in children: an international, multicentre, prospective cohort study GlobalSurg Collaborative To cite: GlobalSurg ABSTRACT Key questions Collaborative. Surgical site Introduction Surgical site infection (SSI) is one of the infection after gastrointestinal most common healthcare- associated infections (HAIs). What is already known? surgery in children: an However, there is a lack of data available about SSI in international, multicentre, There is a lack of data describing the incidence and children worldwide, especially from low- income and ► prospective cohort risk factors for surgical site infection (SSI) in chil- middle- income countries. This study aimed to estimate the study. BMJ Global Health dren. This paucity of data is particularly prevalent incidence of SSI in children and associations between SSI 2020;5:e003429. doi:10.1136/ in low- middle income populations (LMICs), who are and morbidity across human development settings. bmjgh-2020-003429 likely to be affected most by SSI, yet no prospective, Methods A multicentre, international, prospective, multicentric comparative data exist. Handling editor Senjuti Saha validated cohort study of children aged under 16 years undergoing clean- contaminated, contaminated or dirty What are the new findings? ► Additional material is gastrointestinal surgery. Any hospital in the world providing Children undergoing gastrointestinal surgery in low- published online only. To view, ► paediatric surgery was eligible to contribute data between please visit the journal online middle development countries are significantly more (http:// dx. doi. org/ 10. 1136/ January and July 2016. The primary outcome was the likely to have SSIs after surgery than their counter- bmjgh- 2020- 003429).
    [Show full text]